Table 6 |
||||||
|
Effect of EGML or GCE on plasma toxicity biomarkers in overweight subjects |
||||||
|
Groups |
Placebo |
GCE |
EGML |
|||
|
|
||||||
|
Before |
After |
Before |
After |
Before |
After |
|
|
|
||||||
|
GOT (Karman/ml) |
9.96 ± 1.45 |
12.73 ± 2.71 |
9.24 ± 1.07 |
8.61 ± 0.85 |
19.67 ± 8.86 |
11.23 ± 1.27 |
|
GPT (Karman/ml) |
15.10 ± 3.57 |
15.38 ± 2.95 |
11.76 ± 1.50 |
10.15 ± 1.07 |
15.93 ± 2.91 |
15.49 ± 2.07 |
|
|
||||||
|
Values are mean ± S.E.; Data are compared between before and after 10 weeks by Students' t-test, and between groups before and after 10 weeks by one-way ANOVA; GCE, Garcinia cambogia extract; EGML, Extract of Glycine max leaves; GOT, glutamic oxaloacetic transaminase; GPT, glutamic pyruvic transaminase. |
||||||
|
Kim et al. Nutrition Journal 2011 10:94 doi:10.1186/1475-2891-10-94 |
||||||